about
Phosphorylation of caldesmon by mitogen-activated protein kinase with no effect on Ca2+ sensitivity in rabbit smooth muscle.Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states.Microanalytical isotope ratio measurements and elemental mapping using laser ablation ICP-MS for tissue thin sections: zinc tracer studies in rats.A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells.The multi-functional role of sphingosylphosphorylcholine.Sphingolipids in inflammation: pathological implications and potential therapeutic targets.Lysosomes co-localize with ryanodine receptor subtype 3 to form a trigger zone for calcium signalling by NAADP in rat pulmonary arterial smooth muscle.Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation.Long-term zinc deprivation accelerates rat vascular smooth muscle cell proliferation involving the down-regulation of JNK1/2 expression in MAPK signaling.Sphingosylphosphorylcholine inhibits macrophage adhesion to vascular smooth muscle cells.The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP.PEA-15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia.Pertussis toxin sensitive endothelin-1 coupling to inositol phosphate formation via a GTP-binding protein: comparison in SHR and WKY cultured aortic smooth muscle cells.Comparison of endothelin-1 and noradrenaline stimulated inositol phosphate formation in cultured aortic smooth muscle cells from spontaneously hypertensive and Wistar Kyoto rats.Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-alpha-mediated activation of RhoA but dispensable for the activation of the NFET(A) receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathway.Thrombin-induced activation of RhoA in platelet shape change.Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction.Inositol phosphate formation in arterial smooth muscle from rabbits with perinephritis hypertension.Sphingosine 1-phosphate induces CREB activation in rat cerebral artery via a protein kinase C-mediated inhibition of voltage-gated K+ channels.Tumor necrosis factor-alpha-induced activation of RhoA in airway smooth muscle cells: role in the Ca2+ sensitization of myosin light chain20 phosphorylation.Marginal dietary zinc deficiency in vivo induces vascular smooth muscle cell apoptosis in large arteries.Suboptimal dietary zinc intake promotes vascular inflammation and atherogenesis in a mouse model of atherosclerosis.Sphingosine-1-phosphate-induced release of TIMP-2 from vascular smooth muscle cells inhibits angiogenesis.PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: Effects of altered intracellular Ca regulationAgonist desensitisation of alpha 1 adrenoceptors and endothelin-1 receptors coupled to phosphatidylinositol metabolismStimulation of stress-activated but not mitogen-activated protein kinases by tumour necrosis factor receptor subtypes in airway smooth muscleIncreased sensitization of the myofilaments in rat neonatal portal vein: a potential mechanismExpression and distribution of InsP(3) receptor subtypes in proliferating vascular smooth muscle cellsExpression and distribution of the type 1 and type 3 inositol 1,4, 5-trisphosphate receptor in developing vascular smooth muscleTumour necrosis factor-alpha activates a calcium sensitization pathway in guinea-pig bronchial smooth muscleEndothelin-1- and depolarization-induced differential regulation of cAMP response element-binding protein in proliferating and developed vascular smooth muscle
P50
Q30468012-5D7EB2F0-FC36-4C57-A0EE-23799B26E0A1Q34024181-3DC1F29E-7904-4D50-88E3-15992D9185FEQ34050103-CBD536D9-E318-4B77-83A7-FCA76778EBACQ34986520-6E2674E3-F155-439B-B007-5B7107C5AA85Q37016427-8B44C357-08F1-4703-AEEE-BA5892A1E546Q37447464-D3F09768-9A45-42C5-8BDB-B69EB47E057BQ38688613-B54CF8A2-C48F-44F4-B96D-7B64C077B217Q38756914-77F9FB55-FBDE-4F3D-9D8A-6EE76F4A498AQ39184634-F94BC5A8-94BD-4B66-8EED-B4221209AD20Q41841237-B2C6822C-D290-41F3-8C75-6FA610D7550BQ41941935-EFBD70E8-E575-4027-AB04-1A4D1D5CD9EEQ42373761-13984552-3C06-414D-BAE0-1BAB201C4D26Q42480518-22F69D0A-D957-4385-9CCA-0CA2A50CB992Q42501597-A3F9A350-702E-4A86-A5CB-BFD9CFD3094AQ43166315-9FD93D1B-D1B5-42E9-B6F0-889BA758C9A5Q43192104-D0765865-2580-4FB0-8CF5-5B0016A3C1BCQ43732014-2F1A81BF-B585-4E1B-A519-5A01E80AFF56Q44079678-028618E8-EBF5-4BFB-908E-F3555C46BA64Q44297566-199470B6-1A12-4D9B-A01B-5E9CE9CC02E8Q44620636-4A4200C0-C8E1-47B6-BE3B-A0453DF36B2FQ46383399-5B68F308-33CD-4EBF-B29F-B45D8AB514A0Q46678796-62766921-553B-4DB1-B2AA-BC870C6FE4B1Q53159233-BEAA0DC8-7107-4975-9618-DFCF72640E6CQ54528947-C053D6F9-6FFA-4597-9E3B-2D2AEE3B17D8Q63240313-454D1805-AF71-4912-A135-314ED9E7B27EQ72036527-21A29E54-7604-4449-8103-6E5FA1FE359FQ73667162-DC23F541-52DC-44F1-A52D-84867A96B100Q73980527-535D238D-06F3-4E50-A3D1-007845202E32Q73983904-736A6DA7-91D4-46F0-B98E-7E78C2CB4A34Q74615249-89DD2D81-2F16-4058-8218-095CD7A3159AQ77921077-2C348209-44C7-4293-A57B-609A957FE377Q80592887-55C22D73-45F5-40E5-9DDD-F093472EEBEB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Graeme F Nixon
@ast
Graeme F Nixon
@de
Graeme F Nixon
@en
Graeme F Nixon
@es
Graeme F Nixon
@fr
Graeme F Nixon
@it
Graeme F Nixon
@nl
type
label
Graeme F Nixon
@ast
Graeme F Nixon
@de
Graeme F Nixon
@en
Graeme F Nixon
@es
Graeme F Nixon
@fr
Graeme F Nixon
@it
Graeme F Nixon
@nl
prefLabel
Graeme F Nixon
@ast
Graeme F Nixon
@de
Graeme F Nixon
@en
Graeme F Nixon
@es
Graeme F Nixon
@fr
Graeme F Nixon
@it
Graeme F Nixon
@nl
P108
P106
P31
P496
0000-0002-9581-3332